Opendata, web and dolomites

NUTRI-NEED SIGNED

Final development, clinical validation and launch preparation of NL01, an innovative health ingredient for supplements, food products and foods for special medical purposes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NUTRI-NEED project word cloud

Explore the words cloud of the NUTRI-NEED project. It provides you a very rough idea of what is the project "NUTRI-NEED" about.

registration    healthy    humans    crop    preclinical    nutrileads    data    function    elderly    clinical    entry    industrial    ingredient    company    dsm    changer    clinically    fresenius    advice    friesland    ec    adults    demand    foods    track    food    kg    medium    market    nestl    containing    efsa    ingredients    complete    immune    licence    eacute    game    supplements    small    250    inclusion    shown    infection    grant    115    revenues    safety    2026    components    risk    leaders    claims    obtain    proven    dietary    million    isolation    works    regulatory    resistance    medical    licensing    danone    companies    register    functional    huge    approved    purposes    industry    claim    supports    first    representing    46x    infections    population    perform    projected    live    status    launch    young    commercial    supporting    life    isolated    benefits    campina    dynamic    generate    cumulative    patients    people    gt    deals    consumers    plant    proprietary    abbott    nl01    desired    health   

Project "NUTRI-NEED" data sheet

The following table provides information about the project.

Coordinator
NUTRILEADS BV 

Organization address
address: BRONLAND 12 N
city: WAGENINGEN
postcode: 6708 WH
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website https://nutrileads.com/investors/
 Total cost 3˙567˙000 €
 EC max contribution 2˙496˙900 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NUTRILEADS BV NL (WAGENINGEN) coordinator 2˙496˙900.00

Map

 Project objective

People want to live a long and healthy life and there is a huge demand for food products to enable this. Among consumers, the most desired health benefits in food products and supplements are ‘supports immune function’ and ‘increases resistance to infections’.

NutriLeads is a dynamic Health Ingredients company developing crop-derived food ingredients with clinically proven health benefits. With its proprietary lead ingredient NL01, having completed preclinical data and proven safety in humans, NutriLeads is on track to become the first company to launch an ingredient with an approved health claim for supporting immune function and increasing infection resistance. Targeted end-users of NL01 containing food products (dietary supplements, medical- and functional foods) are young adults, adults, elderly and patients, aiming to support their health and immune status.

Nutrileads selected a common crop from which NL01 can be isolated, a game-changer for its commercial success,and developed the isolation process for NL01 up to small scale industrial plant production. In this project, Nutrileads will perform medium scale-up of the production process to 250 kg. Nutrileads will complete the data package for NL01 with a clinical study in a relevant population with increased infection risk to support the health claims on NL01, register NL01 as ‘Novel Food’ and obtain European Food Safety Authority (EFSA) regulatory advice on registration as ‘Food for Specific Medical Purposes’.

NutriLeads will generate revenues from out-licensing NL01 to large companies in the food industry. Market leaders Abbott, Nestlé, Friesland Campina, Danone, Fresenius regularly in-licence components for inclusion in their products; Nestlé and DSM have already shown interest in Nutrileads’ products. Nutrileads works towards market entry and first deals during or directly after this project with a projected best-case cumulative revenues of €115 million in 2026, representing >46x the EC grant.

 Deliverables

List of deliverables.
NL01 brand & logo Websites, patent fillings, videos etc. 2019-08-01 13:00:52

Take a look to the deliverables list in detail:  detailed list of NUTRI-NEED deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NUTRI-NEED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NUTRI-NEED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More  

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More